News
2020-01-17, NEWS
New cheap drug targets therapy resistance in acute myeloid leukaemia
A common and inexpensive drug can be used to counteract treatment resistance in acute myeloid leukemia (AML), one of the most common blood cancer forms in adults, according to a study led by researchers from SciLifeLab and Karolinska Institutet. The study was published in the medical journal EMBO Molecular Medicine and the researchers will now […]
2020-01-14, NEWS
Coordinating safety – Jona Gudjonsdottir helps scientists stay safe
To help researchers work safely and avoid making the same life threatening mistakes she has made in the lab, Jona Gudjonsdottir uses her lifelong experience from various laboratories in her role as Lab Safety Coordinator at SciLifeLab. Before learning what Lab Safety Coordinator Jona Gudjonsdottir actually does for a living, for someone working at SciLifeLab […]
2020-01-13, NEWS
Sleep deprivation might increase the risk of Alzheimer’s disease
Facilitated by the SciLifeLab National Genomics Infrastructure (NGI), researchers have discovered that the blood levels of tau – a biomarker for Alzheimer’s disease – increases when the test subjects were deprived of just one night of sleep. Tau is a protein found in neurons that can form tangles and accumulate in the brains of people with […]
2020-01-08, NEWS
Computer algorithm finds new therapeutic target for neuroblastoma
Based on a new algorithm, TargetTranslator, researchers from SciLifeLab were able to identify a new therapeutic target for neuroblastoma, a form of cancer in the sympathetic nervous system. The algorithm integrates data from tumour biobanks, pharmacological databases, and cellular networks. Neuroblastoma is mainly affecting young children and is responsible for 15 percent of all childhood […]
